Liposomal analgesic formulation and use

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S557000, C514S561000, C514S569000, C514S577000

Reexamination Certificate

active

06936273

ABSTRACT:
A liposome formulation containing about 1% diclofenac is an effective topical anti-inflammatory topical treatment for lameness in horses. More particularly it has been discovered that a formulation containing vitamin E, phospholipid and diclofenac salt such as the sodium or potassium salt is a highly effective topical anti-inflammatory formulation that is particularly effective in treating lameness in horses.

REFERENCES:
patent: 3558690 (1971-01-01), Sallman et al.
patent: 4761288 (1988-08-01), Mezei
patent: 4897269 (1990-01-01), Mezei
patent: 4937078 (1990-06-01), Mezei et al.
patent: 5154930 (1992-10-01), Popescu et al.
patent: 5738869 (1998-04-01), Fischer et al.
patent: 6045827 (2000-04-01), Russell
patent: 6117455 (2000-09-01), Takada et al.
patent: 6287587 (2001-09-01), Shigeyuki et al.
patent: 6423338 (2002-07-01), Larson et al.
International Search Report dated Jul. 2, 2004 for PCT/US03/40717.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Liposomal analgesic formulation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposomal analgesic formulation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomal analgesic formulation and use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3500809

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.